Company
Galvanize Therapeutics
| Industry | commercial-stage medical technology company advancing pulsed electric field (PEF) therapies for oncology and chronic lung disease |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Galvanize Therapeutics | Series C | 2025-09-03 |
Company
| Industry | commercial-stage medical technology company advancing pulsed electric field (PEF) therapies for oncology and chronic lung disease |
|---|
| Company | Round | Date |
|---|---|---|
| Galvanize Therapeutics | Series C | 2025-09-03 |